Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01807975
Other study ID # 2010/56
Secondary ID
Status Completed
Phase N/A
First received March 7, 2013
Last updated July 27, 2016
Start date September 2011
Est. completion date September 2015

Study information

Verified date May 2016
Source Hopital Foch
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

A study to evaluate the role of forced oscillation in precocious diagnosis of bronchiolitis obliterans syndrome in patients with pulmonary transplant (time difference in detecting distal airways functional impairment by forced oscillation and the standard technique using spirometry).


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients of more than 18 year-old.

- Patients with cardiopulmonary transplant or bilateral lung transplant.

- Clinically stable patients

Exclusion Criteria:

- Patients already diagnosed with bronchiolitis obliterans.

- Respiratory infection.

- Acute graft rejection.

- Mechanical complications (bronchial dehiscence, pneumothorax, pleural effusion).

- Iatrogenic pneumopathy.

- Inability to perform Respiratory function test.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Forced oscillation


Locations

Country Name City State
France Hôpital FOCH Suresnes Ile de France

Sponsors (1)

Lead Sponsor Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time difference in diagnosing distal airways functional disturbance by forced oscillation and by spirometry (standard methode). 2 years No
See also
  Status Clinical Trial Phase
Completed NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome Phase 4
Recruiting NCT04391335 - Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children
Recruiting NCT05922761 - BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) Phase 2
Recruiting NCT05250037 - The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
Enrolling by invitation NCT04039347 - Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) Phase 3
Recruiting NCT05413356 - Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome Phase 2
Recruiting NCT00774449 - Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation N/A
Terminated NCT03978637 - Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation Phase 1/Phase 2
Completed NCT02316392 - Imaging and Understanding BOS in Lung Transplantation
Completed NCT00528853 - Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation N/A
Recruiting NCT06018766 - LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. Phase 2
Recruiting NCT02669251 - Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Phase 1/Phase 2
Completed NCT02863835 - Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients N/A
Recruiting NCT03072849 - Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation N/A